NCT06695793

Brief Summary

This study aims to explore the impact of three different suturing techniques (Running, Interrupted \& Locked) that used to close the uterine incision at the cesarean section on the formation of a cesarean scar niche

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Nov 2024Nov 2026

Study Start

First participant enrolled

November 1, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

November 17, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

1.5 years

First QC Date

November 17, 2024

Last Update Submit

November 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of caesarean scar niche and its dimensions.

    Follow-up visits will be scheduled at 6-12 weeks post-cesarean section to assess caesarean section niche formation using trans-vaginal ultrasound using Samsung Elite with endovaginal probe of frequency 6 - 12 MHz. Trained sonographers, blinded to the participants' suturing group, will perform the ultrasound examinations to evaluate caesarean section niche presence and its dimensions.

    6-12 weeks post-cesarean section

Secondary Outcomes (2)

  • Operative time

    during operation

  • Estimate blood loss

    during operation

Study Arms (3)

Group (A)

EXPERIMENTAL

Interrupted Sutures: The first layer of the uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line. Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.

Procedure: Interrupted Sutures

Group (B)

EXPERIMENTAL

Locked Sutures: The first layer of the uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling. The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.

Procedure: Locked Sutures

Group (C)

EXPERIMENTAL

Running Continuous Sutures: Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.

Biological: Running Continuous Sutures

Interventions

The first layer of uterine incision will be closed using individual, separate sutures placed at regular intervals along the incision line. Each suture will be tied independently, ensuring adequate apposition of uterine tissue, followed by a second layer of running continuous sutures.

Group (A)

The first layer of uterine incision will be closed using continuous sutures placed along the uterine incision, incorporating a locking technique at specified intervals to prevent unraveling. The knots will be securely tied to maintain tissue approximation, followed by a second layer of running continuous sutures.

Group (B)

Double layer closure of uterine incision using running continuous suture used to close the uterine incision without interruption, providing seamless tissue approximation throughout the incision length.

Group (C)

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women with a singleton pregnancy scheduled for elective cesarean section
  • Gestational age at the time of cesarean section between 38 and 40 weeks.
  • Willingness to participate in the study and provide informed consent
  • Age between 18 and 35 years old.
  • BMI \<30

You may not qualify if:

  • Known uterine anomalies or previous uterine surgery (e.g, myomectomy, uterine septum resection)
  • Pre-existing medical conditions contraindicating cesarean delivery or affecting uterine healing (e.g., Anemia, Diabetes)
  • Current smokers.
  • Non-cephalic presentation of the fetus.
  • Low-lying anterior wall placenta and placenta previa.
  • Inability to provide informed consent (e.g., cognitive impairment, language barrier)
  • Any condition deemed by the attending physician to pose a risk to the participant or compromise the study's integrity, for example, Patients who will require excessive suturing for further hemostasis or those who require ligation of one or both uterine arteries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Cairo University

Cairo, Egypt

RECRUITING

Cairo University

Cairo, Egypt

RECRUITING

Cairo University

Cairo, Egypt

RECRUITING

Cairo University

Cairo, Egypt

RECRUITING

Cairo University

Cairo, Egypt

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of obgyn Cairo university

Study Record Dates

First Submitted

November 17, 2024

First Posted

November 19, 2024

Study Start

November 1, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

November 19, 2024

Record last verified: 2024-11

Locations